Is myelodysplastic syndrome associated with pruritus?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 12, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

MDS is Associated with Pruritus, Though Uncommonly

Myelodysplastic syndrome (MDS) is associated with pruritus, but this association is relatively uncommon compared to other hematologic malignancies. The pruritus can precede the diagnosis of MDS by months and may be intractable, persisting despite standard antihistamine therapy 1.

Evidence for the Association

The British Association of Dermatologists guidelines 2 discuss haematological causes of generalized pruritus but notably do not specifically list MDS among the primary hematologic conditions associated with pruritus. The guideline emphasizes that polycythemia vera and Hodgkin lymphoma are the main hematologic causes, with myeloma presenting with pruritus "extremely rarely."

However, more recent research evidence demonstrates a clear association:

  • A 2022 large cohort study of 327,502 patients with undifferentiated pruritus found an increased 1-year risk of developing MDS (RR 1.74; 95% CI, 1.14-2.64) 3. Importantly, this elevated risk was only present in the first 12 months and normalized thereafter.

  • A 2019 case series specifically documented intractable pruritus as a primary presentation of both chronic myelomonocytic leukemia (CMML) and MDS 1. In two of these cases, the pruritus preceded the definitive diagnosis by months and was refractory to antihistamines.

  • A 2008 study found that among 84 MDS patients, 3 patients presented with prurigo nodularis 4, and the presence of skin manifestations was a significant predictor of high-risk MDS subgroup.

Clinical Implications

When to Suspect MDS in Pruritic Patients

Look for these specific features:

  • Intractable pruritus unresponsive to antihistamines
  • Absence of primary skin lesions (or only secondary excoriations)
  • Associated constitutional symptoms: fatigue, weight loss, fever
  • Any unexplained cytopenias on complete blood count

Diagnostic Approach

For patients with unexplained generalized pruritus 2:

  • Obtain full blood count with blood film, lactate dehydrogenase, and ESR
  • Note that LDH has limited diagnostic utility in pruritus workup despite being commonly ordered 3
  • If cytopenias or monocytosis are present, proceed to bone marrow biopsy for definitive diagnosis 1

Important Caveats

  • The pruritus may precede diagnostic features of MDS by months 1, making early diagnosis challenging
  • Unlike polycythemia vera where aquagenic pruritus is characteristic, MDS-associated pruritus has no specific pattern
  • The pathogenesis remains unclear but appears linked to the underlying biology of the myeloid disorder 1
  • Treatment of the pruritus is difficult; in one case, it persisted despite achieving morphological remission with azacitidine but responded to cladribine 1

Bottom Line

While MDS is not among the most common hematologic causes of pruritus (unlike polycythemia vera or Hodgkin lymphoma), clinicians should maintain a high index of suspicion for MDS in patients with intractable, unexplained pruritus, particularly when accompanied by cytopenias. The pruritus can be a harbinger of MDS, appearing months before definitive diagnostic features emerge.

References

4
Research

Cutaneous manifestations in relation to immunologic parameters in a cohort of primary myelodysplastic syndrome patients.

Journal of the European Academy of Dermatology and Venereology : JEADV, 2008

Related Questions

Is myelodysplastic syndrome associated with skin fragility?
With negative cytogenetic testing for myelodysplastic syndrome and all medications discontinued to exclude drug‑induced or autoimmune cytopenias, what are the appropriate next diagnostic and management steps?
Do myelodysplastic syndromes have cutaneous manifestations?
How is myelodysplastic syndrome diagnosed?
Is myelodysplastic syndrome considered a malignancy?
Do myelodysplastic syndromes have cutaneous manifestations?
What is the most likely composite diagnosis for a 24‑year‑old female with post‑traumatic stress disorder (PTSD), major depressive disorder (MDD), generalized anxiety disorder (GAD), obsessive‑compulsive disorder (OCD), and an unspecified eating disorder characterized by alternating restriction and binge‑eating cycles?
Is myelodysplastic syndrome associated with skin fragility?
What is the optimal antibiotic treatment for uncomplicated cystitis in a lactating patient with no drug allergies and normal laboratory results?
What is the appropriate workup and management for pruritus on the forearms with associated skin bruising?
Does oil of oregano effectively treat sinus congestion, and what is the appropriate dosage and administration method for an adult without contraindications?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.